DE60139002D1 - Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält - Google Patents

Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält

Info

Publication number
DE60139002D1
DE60139002D1 DE60139002T DE60139002T DE60139002D1 DE 60139002 D1 DE60139002 D1 DE 60139002D1 DE 60139002 T DE60139002 T DE 60139002T DE 60139002 T DE60139002 T DE 60139002T DE 60139002 D1 DE60139002 D1 DE 60139002D1
Authority
DE
Germany
Prior art keywords
prostaglandine
keto
supplement
liver transplant
transplant containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139002T
Other languages
German (de)
English (en)
Inventor
Ryuji Ueno
Makoto Suematsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Application granted granted Critical
Publication of DE60139002D1 publication Critical patent/DE60139002D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60139002T 2000-04-06 2001-04-05 Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält Expired - Lifetime DE60139002D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19489400P 2000-04-06 2000-04-06
PCT/JP2001/002938 WO2001076593A2 (en) 2000-04-06 2001-04-05 Bile secretion promoting composition a 15-keto prostaglandin

Publications (1)

Publication Number Publication Date
DE60139002D1 true DE60139002D1 (de) 2009-07-30

Family

ID=22719290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139002T Expired - Lifetime DE60139002D1 (de) 2000-04-06 2001-04-05 Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält

Country Status (15)

Country Link
US (2) US6469062B2 (enExample)
EP (1) EP1267883B1 (enExample)
JP (2) JP4183943B2 (enExample)
KR (1) KR100874626B1 (enExample)
CN (1) CN1241570C (enExample)
AR (1) AR030277A1 (enExample)
AT (1) ATE433754T1 (enExample)
AU (2) AU2001244727B2 (enExample)
BR (1) BR0107544A (enExample)
CA (1) CA2404767C (enExample)
DE (1) DE60139002D1 (enExample)
MX (1) MXPA02009915A (enExample)
NZ (1) NZ521784A (enExample)
TW (1) TWI232750B (enExample)
WO (1) WO2001076593A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139002D1 (de) * 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
ES2591252T3 (es) * 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional
CN101198334B (zh) * 2005-04-12 2013-02-06 苏坎波公司 前列腺素化合物和质子泵抑制剂用于治疗肠胃病的联合应用
WO2007008697A2 (en) * 2005-07-08 2007-01-18 University Of Chicago Compositions and methods for refolding of denatured proteins
MX2008011148A (es) * 2006-02-28 2008-09-08 Sucampo Ag Metodo y composicion para tratar enfermedad pulmonar obstructiva cronica.
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
WO2018065826A1 (en) * 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use
KR102595299B1 (ko) 2020-10-12 2023-10-26 류형준 담즙 분비 촉진 효능이 있는 식품 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS6327433A (ja) 1986-07-21 1988-02-05 Teijin Ltd 肝疾患治療剤
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5076569A (en) * 1989-09-15 1991-12-31 Gootter Steven M Contoured grip for exercising the hand
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
JPH069404A (ja) 1992-06-23 1994-01-18 Ono Pharmaceut Co Ltd 臓器移植用薬剤
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
DE60139002D1 (de) * 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält

Also Published As

Publication number Publication date
NZ521784A (en) 2005-04-29
WO2001076593A2 (en) 2001-10-18
KR20020087123A (ko) 2002-11-21
AR030277A1 (es) 2003-08-20
US6469062B2 (en) 2002-10-22
CA2404767A1 (en) 2001-10-18
TWI232750B (en) 2005-05-21
WO2001076593A3 (en) 2002-07-11
AU2001244727B2 (en) 2006-08-10
JP2008291033A (ja) 2008-12-04
KR100874626B1 (ko) 2008-12-17
CN1450899A (zh) 2003-10-22
CA2404767C (en) 2010-12-07
CN1241570C (zh) 2006-02-15
EP1267883A2 (en) 2003-01-02
JP4183943B2 (ja) 2008-11-19
EP1267883B1 (en) 2009-06-17
JP2004519412A (ja) 2004-07-02
US20030060506A1 (en) 2003-03-27
AU4472701A (en) 2001-10-23
US20020004524A1 (en) 2002-01-10
BR0107544A (pt) 2005-01-11
JP5073588B2 (ja) 2012-11-14
MXPA02009915A (es) 2003-03-27
ATE433754T1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
DE69919080D1 (de) Pufferstruktur für ein Laufband
DE60109013D1 (de) Flüssigkeitsverlust kontrollierendes Zusatzmittel für Bohrlochzement
DE10085249T1 (de) Stoßbegrenzende Aufhängung für ein Plattenlaufwerk
DE69933583D1 (de) Spielzeug für haustiere
NO20033074L (no) Antistoffer mot reseptoren for insulin-lignende vekstfaktor I
DE60106022D1 (de) Thiophenverbindungen zur verwendung als antikrebsmittel
DE60119217D1 (de) Radaufhängung für ein Fahrzeug
NO20006114D0 (no) Nytt 3-aryl-2-hydroksypropionsyrederivat III
DE60139002D1 (de) Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
ME00562A (en) Novel salt form of pantoprazole
DE60029024D1 (de) Verpackung für ein Seifenstück
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
FR2813756B1 (fr) Dilueur pour la conservation de spermatozoides de porcins
DE60044043D1 (de) Messsteuerung für ein Fahrzeug
DE50012872D1 (de) Hohlkolben für eine Kolbenmaschine
DE10031213B4 (de) Dichtungsband für Fugen
DE69903071D1 (de) Fänger für fluorwasserstoffsäure
DE60106106D1 (de) Fahrwegsteuersystem für ein Fahrzeug
DK0799223T3 (da) Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler
DE50101998D1 (de) Bearbeitungsaggregat für ein bearbeitungszentrum
DE60115364D1 (de) Herstellungsverfahren für stranggussknüppel
DE60128812D1 (de) Ansteuerschaltung für ein lichtemittierendes bauelement
NO20012377L (no) Fordelt maskinstruktur for skip
DE60020030D1 (de) Dichtungsmanschette für ein Gleichlaufgelenk
NO20024247L (no) Pyridazinylfenylhydrazoner nyttige mot kongestiv hjertesvikt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition